Data / Form D filings / UroGen Pharma Ltd.
UroGen Pharma Ltd.: Form D filing
UroGen Pharma Ltd., a pharmaceuticals company in Princeton, NJ, filed a Form D with the SEC in 2023. The latest, on August 14, 2023, reports $120 million sold of a $120 million offering to 8 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 400 Alexander Park Drive, 4th Floor, Princeton, NJ, 08540
- Phone
- (646) 768-9780
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Israel
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1668243
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 14, 2023 | New notice | $120,000,000 | $120,000,000 | 8 | Jul 26, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Stuart Holden, M.D. | Director | |
| Jason A. Smith | Executive Officer | |
| Arie Belldegrun, M.D. | Director | |
| Dan Wildman | Director | |
| Fred Cohen, M.D. | Director | |
| Don Kim | Executive Officer | |
| James A. Robinson, Jr. | Director | |
| Cynthia Butitta | Director | |
| Ran Nussbaum | Director | |
| Elizabeth Barrett | Executive Officer, Director | |
| Leana Wen, M.D., MSc | Director | |
| Mark A. Schoenberg, M.D. | Executive Officer |
Other pharmaceuticals companies in New Jersey that filed recently
- Grace Therapeutics, Inc. $10 million · Aug 11, 2026
Every Form D from the week of Aug 14, 2023 · All recent filings in New Jersey · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what UroGen Pharma Ltd. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.